CHM chimeric therapeutics limited

IMU is more likely to end up with 100b shares on issue than...

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    IMU is more likely to end up with 100b shares on issue than market valuation given the current cash burn rate.

    don’t get me wrong, I wish IMU every success. Will be good for the local biotech sector if the company shoots the lights out, with cashed up, risk averse biotech shareholders!

    Just not overly impressed by IMUs therapy pipeline and management on a relative and absolute basis. Happy to be corrected on any of my comments.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.